These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29924071)

  • 21. Therapy for Spinal Muscular Atrophy.
    Finkel RS; Farwell W
    N Engl J Med; 2018 Feb; 378(5):487-488. PubMed ID: 29385371
    [No Abstract]   [Full Text] [Related]  

  • 22. Infantile spinal progressive muscular atrophy in twins.
    POIRIER R; CORBET RC; BUCKWOLD AE
    Can Med Assoc J; 1951 Oct; 65(4):342-3. PubMed ID: 14879299
    [No Abstract]   [Full Text] [Related]  

  • 23. Stakeholder collaboration for spinal muscular atrophy therapy development.
    Aartsma-Rus A; Balabanov P; Binetti L; Haas M; Haberkamp M; Mitchell J; Rosa MM; Muntoni F; Finkel R; Mercuri E
    Lancet Neurol; 2017 Apr; 16(4):264. PubMed ID: 28327335
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the morphology, nosological position and pathogenesis of Oppenheim's myotonia congenita and Werdnig-Hoffmann's infantile spinal progressive muscular atrophy].
    GEILER G; GEILER G
    Virchows Arch Pathol Anat Physiol Klin Med; 1962; 335():654-67. PubMed ID: 13897523
    [No Abstract]   [Full Text] [Related]  

  • 25. Hereditary factors in infantile progressive muscular atrophy; study of 112 cases in 70 families.
    BRANDT S
    Am J Dis Child (1911); 1949 Aug; 78(2):226-36. PubMed ID: 18135521
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetic therapies for spinal muscular atrophy type 1.
    Aartsma-Rus A
    Lancet Neurol; 2018 Feb; 17(2):111-112. PubMed ID: 29229374
    [No Abstract]   [Full Text] [Related]  

  • 27. [Difficulty in surrogate decision making in spinal muscular atrophy type 1].
    Laxe S
    An Pediatr (Barc); 2016 Sep; 85(3):165. PubMed ID: 27198884
    [No Abstract]   [Full Text] [Related]  

  • 28. New Frontiers in the Treatment of Spinal Muscular Atrophy.
    Power CL; O'Rourke DJ
    Ir Med J; 2018 Mar; 111(3):705. PubMed ID: 30376223
    [No Abstract]   [Full Text] [Related]  

  • 29. Spinal muscular atrophy with respiratory distress type 1 (SMARD1).
    Kaindl AM; Guenther UP; Rudnik-Schöneborn S; Varon R; Zerres K; Schuelke M; Hübner C; von Au K
    J Child Neurol; 2008 Feb; 23(2):199-204. PubMed ID: 18263757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Turning the tide in spinal muscular atrophy: A different respiratory course.
    Mayer OH
    Pediatr Pulmonol; 2019 Jul; 54(7):935-936. PubMed ID: 30884211
    [No Abstract]   [Full Text] [Related]  

  • 31. [CASE OF MYELOPATHIC MUSCULAR ATROPHY THOUGHT AT FIRST TO BE PROGRESSIVE MUSCULAR DYSTROPHY--A VIEW OF THE RELATION BETWEEN KUGELBERG-WELANDER'S MUSCULAR ATROPHY AND WERDNIG-HOFFMANN DISEASE].
    FURUKAWA S; MAMIYA S
    Nihon Shonika Gakkai Zasshi; 1963 Nov; 67():745-8. PubMed ID: 14096316
    [No Abstract]   [Full Text] [Related]  

  • 32. Course and symptoms of progressive infantile muscular atrophy; a follow-up study of 112 cases in Denmark.
    BRANDT S
    Arch Neurol Psychiatry; 1950 Feb; 63(2):218-28. PubMed ID: 15404484
    [No Abstract]   [Full Text] [Related]  

  • 33. Exome Sequencing Identifies DYNC1H1 Variant Associated With Vertebral Abnormality and Spinal Muscular Atrophy With Lower Extremity Predominance.
    Punetha J; Monges S; Franchi ME; Hoffman EP; Cirak S; Tesi-Rocha C
    Pediatr Neurol; 2015 Feb; 52(2):239-44. PubMed ID: 25484024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current and future treatments of spinal muscular atrophy.
    Smith M
    Dev Med Child Neurol; 2020 Mar; 62(3):267. PubMed ID: 31879942
    [No Abstract]   [Full Text] [Related]  

  • 35. Mitochondrial respiratory complex I deficiency simulating spinal muscular atrophy.
    Lee JS; Hwang JS; Ryu KH; Lee EH; Kim SH
    Pediatr Neurol; 2007 Jan; 36(1):45-7. PubMed ID: 17162196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention and management of limb contractures in neuromuscular diseases.
    Skalsky AJ; McDonald CM
    Phys Med Rehabil Clin N Am; 2012 Aug; 23(3):675-87. PubMed ID: 22938881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Infantile spinal muscular atrophy. Description of 2 cases of Werdnig-Hoffmann disease].
    Priora U; Quaglia P; Vivalda M; Giachino-Amistà MT; Domeneghetti G; Sardi R
    Minerva Pediatr; 1987 Sep; 39(17-18):709-14. PubMed ID: 3437861
    [No Abstract]   [Full Text] [Related]  

  • 38. Systematic Review of Motor Function Scales and Patient-Reported Outcomes in Spinal Muscular Atrophy.
    Wu JW; Pepler L; Maturi B; Afonso ACF; Sarmiento J; Haldenby R
    Am J Phys Med Rehabil; 2022 Jun; 101(6):590-608. PubMed ID: 34483260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of muscle strength with a handheld dynamometer in patients with chronic spinal muscular atrophy.
    Febrer A; Rodriguez N; Alias L; Tizzano E
    J Rehabil Med; 2010 Mar; 42(3):228-31. PubMed ID: 20411217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The gross motor function measure is a valid and sensitive outcome measure for spinal muscular atrophy.
    Nelson L; Owens H; Hynan LS; Iannaccone ST;
    Neuromuscul Disord; 2006 Jun; 16(6):374-80. PubMed ID: 16632361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.